Suanfarma, a life science business, announced a strategic rebranding initiative aimed at reinforcing Suanfarma as a global player in the healthcare sector, both as a distributor of APIs and as a CDMO in the production of active pharmaceutical ingredients. 
 
Suanfarma’s sites, Cipan in Portugal and Rovereto in Italy, are now acknowledged as part of a global and unified brand. Suanfarma CDMO enhances visibility and flexibility in new projects, and enables the companies to leverage synergies among the two factories.
 
“We have grown significantly in the last few years in our CDMO capabilities, and now we want to showcase who we truly are. At Suanfarma CDMO, we adapt to the customers’ needs for fermentation, purification, and chemical synthesis processes in small, mid, and large volumes,” said Francisco Fernández, CEO of Suanfarma.
 
“We recognize that a strong corporate brand is crucial for success in today’s competitive business environment. The new brand architecture is a representation of our commitment to corporate excellence, setting the stage for enhanced trust and recognition among global stakeholders,” said Daniel Rivero, Industrial Director of Suanfarma.